Novavax (NVAX) Reports Q3 Loss of $3.21/sh
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $9.74 +2.96%
EPS Growth %: -164.5%
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
CRMT, More
EPS Growth %: -164.5%
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q3 EPS of ($3.21), versus $0.74 reported last year. Revenue for the quarter came in at $157 million versus the consensus estimate of $230.56 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Elevance (ELV) PT Raised to $482 at Bernstein SocGen
- Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
